To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF259TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
349 supporting clones for gene ZNF259 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CD109458 Human Placenta, placenta .a 1 to 737 12 to 750       739/768
(96 %)
13 diff
(98.4 %id)
CD359945 testis .a 1 to 870 1 to 876   tiling clone,   876/881
(99 %)
9 diff
(99.0 %id)
BI459914 testis .a 7 to 679 1 to 668       668/668
(100 %)
9 diff
(98.7 %id)
BG897930 cartilage .a 8 to 667 49 to 708       660/669
(98 %)
11 diff
(98.4 %id)
TI_44350443   .a 11 to 723 113 to 832       720/833
(86 %)
23 diff
(97.3 %id)
BG702611 brain, hippocampus .a 13 to 786 1 to 774       774/774
(100 %)
16 diff
(98.0 %id)
BI561910 testis .a 14 to 723 1 to 717       717/718
(99 %)
21 diff
(97.1 %id)
DB459476 testis .a 15 to 502 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
BC017349 Brain, astrocytoma, grade IV .a 16 to 1792 1 to 1777 exact tiling clone, available from MGC, AAA   1777/1777
(100 %)
0 diff
(100 %id)
NM_003904.3   .a 16 to 1792 1 to 1777 exact RefSeq, AAA   1777/1777
(100 %)
0 diff
(100 %id)
BG823735 adenocarcinoma cell line, colon .a 17 to 794 1 to 778       778/944
(82 %)
20 diff
(97.9 %id)
BQ897942 epidermoid carcinoma, cell line, salivary gland .a 17 to 809 1 to 797       797/870
(91 %)
11 diff
(98.8 %id)
BQ670096 epidermoid carcinoma, cell line, salivary gland .a 17 to 866 1 to 856       853/894
(95 %)
7 diff
(99.3 %id)
BU180461 epidermoid carcinoma, cell line, salivary gland .a 17 to 687 1 to 682       682/981
(69 %)
25 diff
(97.5 %id)
BQ671770 epidermoid carcinoma, cell line, salivary gland .a 17 to 471 1 to 455       455/1080
(42 %)
10 diff
(99.1 %id)
BQ671401 epidermoid carcinoma, cell line, salivary gland .a 17 to 758 1 to 748       748/981
(76 %)
9 diff
(99.1 %id)
BQ674372 epidermoid carcinoma, cell line, salivary gland .a 17 to 939 1 to 927       926/927
(99 %)
13 diff
(98.6 %id)
CR590018 B cells (Ramos cell line) Cot 25-normalized .a 22 to 1760 1 to 1739 exact     1739/1739
(100 %)
0 diff
(100 %id)
AL561342 B cells from Burkitt lymphoma .a 22 to 899 1 to 877   fully sequenced,   877/877
(100 %)
3 diff
(99.7 %id)
BI193161 epithelioid carcinoma cell line, Pancreas .a 22 to 641 1 to 618       618/701
(88 %)
14 diff
(98.1 %id)
BM011917 brain, neuroblastoma, cell line .a 22 to 622 1 to 607       607/611
(99 %)
13 diff
(97.9 %id)
BM805934 brain, hippocampus .a 23 to 630 6 to 615       610/1172
(52 %)
9 diff
(99.3 %id)
CB215309 normal endometrium, late proliferativephase, cycle day 13, uterus .a 23 to 642 1 to 620       620/620
(100 %)
2 diff
(99.7 %id)
TI_59381101   .a 23 to 622 93 to 698       606/610
(99 %)
12 diff
(98.1 %id)
TI_57170335   .a 24 to 644 29 to 645       617/645
(95 %)
10 diff
(98.5 %id)
BX366717 Placenta Cot 25-normalized .a 25 to 1021 1 to 993       993/1064
(93 %)
16 diff
(98.5 %id)
BG821381 adenocarcinoma cell line, colon .a 25 to 706 1 to 690       690/690
(100 %)
14 diff
(98.0 %id)
BQ954247 brain, neuroblastoma, cell line .a 25 to 752 1 to 734       734/953
(77 %)
10 diff
(99.0 %id)
CN425522 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 26 to 645 12 to 631       620/631
(98 %)
6 diff
(99.1 %id)
BI825774 brain, medulla .a 27 to 644 1 to 614       614/614
(100 %)
14 diff
(97.8 %id)
AL552469 placenta, Placenta Cot 25-normalized .a 28 to 989 1 to 959       959/960
(99 %)
14 diff
(98.6 %id)
CD675053 eye, lens .a 28 to 558 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BF688211 eye, normal pigmented retinal epithelium .a 28 to 746 1 to 734       734/1097
(66 %)
42 diff
(96.2 %id)
BI520520 brain, medulla .a 28 to 726 1 to 715       644/725
(88 %)
34 diff
(95.4 %id)
BM450633 eye, retinoblastoma .a 28 to 797 1 to 771       771/1010
(76 %)
9 diff
(99.2 %id)
TI_43963684   .a 28 to 726 59 to 773       564/786
(71 %)
32 diff
(96.0 %id)
BC111028 Brain, fetal, whole pooled .a 29 to 1792 1 to 1764 exact AAA   1764/1764
(100 %)
0 diff
(100 %id)
BM801004 melanotic melanoma, skin .a 29 to 592 1 to 565       565/1139
(49 %)
16 diff
(98.6 %id)
CX866572 embryonic stem .a 29 to 868 1 to 840       840/840
(100 %)
0 diff
(100 %id)
CD579420 brain .a 29 to 940 1 to 903       907/944
(96 %)
32 diff
(96.7 %id)
BG821508 adenocarcinoma cell line, colon .a 30 to 799 1 to 770       770/827
(93 %)
8 diff
(99.1 %id)
BI115921 lung, small cell carcinoma .a 30 to 544 1 to 515       515/808
(63 %)
16 diff
(98.1 %id)
BG281255 melanotic melanoma, skin .a 32 to 573 1 to 547       547/1038
(52 %)
15 diff
(98.6 %id)
BG334681 melanotic melanoma, skin .a 32 to 754 1 to 718       718/787
(91 %)
10 diff
(98.8 %id)
BG477946 melanotic melanoma, skin .a 32 to 703 1 to 673       673/673
(100 %)
17 diff
(97.5 %id)
BG478776 melanotic melanoma, skin .a 32 to 775 1 to 743       743/743
(100 %)
17 diff
(97.8 %id)
BM910418 astrocytoma grade IV, cell line, brain .a 32 to 943 1 to 921       921/1021
(90 %)
9 diff
(99.2 %id)
BC012162 Skin, melanotic melanoma. .a 33 to 1792 1 to 1760 exact available from MGC, AAA   1760/1760
(100 %)
0 diff
(100 %id)
BC017380 Skin, melanotic melanoma. .a 33 to 1792 1 to 1760   available from MGC, AAA   1760/1760
(100 %)
0 diff
(100 %id)
BE276112 melanotic melanoma, skin .a 33 to 705 38 to 706       669/731
(91 %)
12 diff
(98.4 %id)
BQ960037 leiomyosarcoma, uterus .a 34 to 967 1 to 940       940/943
(99 %)
23 diff
(97.6 %id)
BG104209 melanotic melanoma, skin .a 36 to 752 1 to 713       713/927
(76 %)
16 diff
(98.3 %id)
BG280991 melanotic melanoma, skin .a 36 to 754 1 to 717       717/751
(95 %)
14 diff
(98.2 %id)
DR002504 fetal brain .a 36 to 723 7 to 692       686/692
(99 %)
9 diff
(98.7 %id)
CR626297 Neuroblastoma Cot 10-normalized .a 37 to 1778 1 to 1742 exact     1742/1742
(100 %)
0 diff
(100 %id)
AL522413 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 37 to 851 1 to 816   fully sequenced,   816/816
(100 %)
1 diff
(99.9 %id)
BC011929 Skin, melanotic melanoma. .a 37 to 1792 1 to 1755 E206K N207T P208H H209M A210L ... available from MGC, AAA   1755/1755
(100 %)
1 diff
(100.0 %id)
BQ647062 hepatocellular carcinoma, cell line, Liver .a 38 to 630 25 to 615       591/1077
(54 %)
23 diff
(97.9 %id)
BM928675 hepatocellular carcinoma, cell line, Liver .a 39 to 754 1 to 719       719/1053
(68 %)
10 diff
(99.1 %id)
BQ643553 hepatocellular carcinoma, cell line, Liver .a 39 to 985 1 to 960       959/961
(99 %)
21 diff
(97.9 %id)
BQ651494 hepatocellular carcinoma, cell line, Liver .a 39 to 951 1 to 915       913/929
(98 %)
6 diff
(99.4 %id)
BQ651632 hepatocellular carcinoma, cell line, Liver .a 39 to 882 1 to 846       846/849
(99 %)
4 diff
(99.6 %id)
BQ649624 hepatocellular carcinoma, cell line, Liver .a 39 to 757 1 to 722       722/937
(77 %)
13 diff
(98.7 %id)
BQ649554 hepatocellular carcinoma, cell line, Liver .a 39 to 813 1 to 778       777/976
(79 %)
14 diff
(98.6 %id)
TI_57174926   .a 39 to 719 27 to 740       607/747
(81 %)
36 diff
(95.2 %id)
BE272078 adenocarcinoma cell line, ovary .a 40 to 714 1 to 668       668/677
(98 %)
11 diff
(98.4 %id)
BE747078 adenocarcinoma cell line, ovary .a 40 to 851 1 to 810       810/911
(88 %)
27 diff
(97.1 %id)
BE258315 eye, retinoblastoma .a 42 to 722 1 to 677       677/683
(99 %)
13 diff
(98.1 %id)
BE791083 lung, small cell carcinoma .a 42 to 758 1 to 714       714/1248
(57 %)
28 diff
(97.8 %id)
BF685358 leiomyosarcoma cell line, uterus .a 42 to 810 1 to 757       761/784
(97 %)
33 diff
(95.8 %id)
BI117205 lung, small cell carcinoma .a 43 to 735 1 to 696       696/898
(77 %)
27 diff
(97.0 %id)
BU169812 epithelioid carcinoma, Pancreas .a 43 to 630 7 to 595       589/888
(66 %)
13 diff
(98.6 %id)
TI_1948130670   .a 43 to 753 120 to 830       711/1093
(65 %)
14 diff
(98.8 %id)
TI_1948131327   .a 43 to 713 121 to 791       671/1110
(60 %)
26 diff
(97.7 %id)
TI_1948131328   .a 43 to 757 120 to 847       728/1289
(56 %)
34 diff
(97.4 %id)
BM449451 eye, retinoblastoma .a 44 to 634 1 to 591       591/1096
(53 %)
18 diff
(98.4 %id)
BF312158 brain, neuroblastoma .a 45 to 804 1 to 755       755/892
(84 %)
9 diff
(99.0 %id)
BG331708 large cell carcinoma, lung .a 45 to 753 1 to 709       709/917
(77 %)
27 diff
(97.1 %id)
BG420606 Kidney, renal cell adenocarcinoma .a 45 to 800 1 to 754       754/936
(80 %)
18 diff
(98.1 %id)
BC004256 Pancreas, adenocarcinoma .a 46 to 1792 1 to 1747 exact available from MGC, AAA   1747/1747
(100 %)
0 diff
(100 %id)
BF725798 eye, Iris .a 46 to 630 1 to 585       585/586
(99 %)
0 diff
(100 %id)
BM563467 brain, medulla .a 46 to 1029 1 to 998       998/1096
(91 %)
24 diff
(97.9 %id)
CX751187 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 46 to 707 1 to 662     Submitted on the opposite strand 662/662
(100 %)
0 diff
(100 %id)
BE616651 adenocarcinoma, Pancreas .a 47 to 687 1 to 647       647/896
(72 %)
28 diff
(96.9 %id)
BF688709 eye, normal pigmented retinal epithelium .a 48 to 711 1 to 677       677/1031
(65 %)
38 diff
(96.4 %id)
BT006642   .a 49 to 1428 1 to 1380 exact     1380/1380
(100 %)
0 diff
(100 %id)
CR594434 Placenta Cot 25-normalized .a 49 to 1763 1 to 1715 exact     1715/1715
(100 %)
0 diff
(100 %id)
AL547703 placenta, Placenta Cot 25-normalized .a 49 to 994 1 to 937       937/983
(95 %)
15 diff
(98.5 %id)
BX402314 Placenta Cot 25-normalized .a 49 to 1083 1 to 1023       1023/1069
(95 %)
66 diff
(93.9 %id)
CV026330 mixed .a 49 to 713 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
AL528788 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 50 to 1058 1 to 1004   fully sequenced,   1004/1004
(100 %)
7 diff
(99.4 %id)
AL556360 placenta .a 50 to 940 1 to 898       896/898
(99 %)
29 diff
(96.8 %id)
BE276762 melanotic melanoma, skin .a 51 to 681 1 to 636       636/637
(99 %)
13 diff
(98.0 %id)
BM451890 eye, retinoblastoma .a 51 to 756 25 to 731       707/922
(76 %)
26 diff
(97.2 %id)
BQ641496 eye, normal pigmented retinal epithelium .a 51 to 813 1 to 766       766/932
(82 %)
13 diff
(98.7 %id)
BQ641510 eye, normal pigmented retinal epithelium .a 51 to 813 1 to 770       769/927
(82 %)
17 diff
(98.2 %id)
TI_1948130671   .a 51 to 630 137 to 716       580/1157
(50 %)
21 diff
(98.2 %id)
BE391123 endometrium, adenocarcinoma cell line, uterus .a 52 to 723 1 to 669       669/671
(99 %)
7 diff
(99.0 %id)
BI917931 brain .a 52 to 692 20 to 653       634/653
(97 %)
12 diff
(98.2 %id)
BU557414 ovary, teratocarcinoma, cell line .a 52 to 747 1 to 703       703/937
(75 %)
9 diff
(99.1 %id)
TI_57242526   .a 52 to 692 49 to 682       634/682
(92 %)
13 diff
(98.1 %id)
AK301227 Spleen .a 53 to 1491 1 to 1439       1439/1439
(100 %)
0 diff
(100 %id)
DA082965 cerebellum .a 53 to 616 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AL516138 brain, neuroblastoma, neuroblastoma cells .a 53 to 933 1 to 881       881/881
(100 %)
4 diff
(99.6 %id)
DB037129 testis .a 53 to 638 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BM564399 blood, natural killer cells, cell line .a 54 to 754 1 to 703       703/1179
(59 %)
8 diff
(99.4 %id)
DA953650 Spleen .a 54 to 650 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
BE389797 endometrium, adenocarcinoma cell line, uterus .a 55 to 705 1 to 646       646/693
(93 %)
13 diff
(98.2 %id)
BF026616 melanotic melanoma, skin .a 55 to 757 1 to 712       712/714
(99 %)
37 diff
(94.9 %id)
BQ944231 carcinoma, cell line, Prostate .a 55 to 754 1 to 704       704/957
(73 %)
14 diff
(98.6 %id)
BQ945398 carcinoma, cell line, Prostate .a 55 to 943 1 to 888       888/955
(92 %)
8 diff
(99.2 %id)
BU542515 carcinoma, cell line, Prostate .a 55 to 939 1 to 885       885/885
(100 %)
8 diff
(99.1 %id)
BE385905 melanotic melanoma, skin .a 56 to 688 1 to 630       630/632
(99 %)
14 diff
(97.8 %id)
BE727761 melanotic melanoma, skin .a 56 to 686 1 to 636       597/636
(93 %)
40 diff
(93.8 %id)
BE900414 choriocarcinoma, placenta .a 63 to 725 1 to 640       607/660
(91 %)
49 diff
(92.6 %id)
BE901619 choriocarcinoma, placenta .a 63 to 681 1 to 615       613/880
(69 %)
11 diff
(98.8 %id)
BP196890 adrenal gland .a 64 to 645 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP364518 lung .a 64 to 645 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BE563710 adenocarcinoma, Pancreas .a 66 to 813 1 to 767       763/843
(90 %)
41 diff
(95.2 %id)
BE904140 epithelioid carcinoma, Pancreas .a 70 to 754 1 to 684       684/1084
(63 %)
27 diff
(97.6 %id)
BG031644 breast, mammary adenocarcinoma, cell line .a 77 to 757 56 to 708       630/966
(65 %)
39 diff
(96.0 %id)
BQ069170 brain, neuroblastoma, cell line .a 78 to 943 1 to 872       872/1014
(85 %)
8 diff
(99.3 %id)
BE615909 adenocarcinoma, Pancreas .a 121 to 739 47 to 658       612/660
(92 %)
17 diff
(97.5 %id)
CD617675   .a 151 to 717 1 to 567       567/571
(99 %)
15 diff
(97.4 %id)
DA176584 amygdala .a 154 to 717 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BI115675 lung, small cell carcinoma .a 165 to 873 1 to 711       711/787
(90 %)
15 diff
(98.1 %id)
CR974694 T-Lymphocytes .a 169 to 793 1 to 625       625/630
(99 %)
1 diff
(99.9 %id)
CT002675 T-Lymphocytes .a 169 to 694 1 to 526       526/528
(99 %)
1 diff
(99.9 %id)
CR998095 T-Lymphocytes .a 169 to 578 1 to 410       410/412
(99 %)
1 diff
(99.8 %id)
CT004681 T-Lymphocytes .a 169 to 698 1 to 530       530/530
(100 %)
0 diff
(100 %id)
CT004799 T-Lymphocytes .a 169 to 987 1 to 819       819/819
(100 %)
1 diff
(99.9 %id)
BM750969 Ascites, stomach .a 178 to 628 1 to 451       451/451
(100 %)
4 diff
(99.2 %id)
BQ348360 head_neck .a 184 to 711 530 to 3       528/533
(99 %)
6 diff
(98.9 %id)
BF983105 duodenal adenocarcinoma, cell line, small intestine .a 193 to 867 1 to 675       675/952
(70 %)
10 diff
(99.0 %id)
BF350165 head_neck .a 199 to 649 1 to 451       451/451
(100 %)
3 diff
(99.4 %id)
BG821733 adenocarcinoma cell line, colon .a 203 to 1134 1 to 928       928/951
(97 %)
16 diff
(98.4 %id)
AW370438 breast .a 220 to 785 570 to 4       567/570
(99 %)
5 diff
(99.2 %id)
BE741446 adenocarcinoma cell line, ovary .a 247 to 785 1 to 538       538/538
(100 %)
2 diff
(99.7 %id)
BE815647 breast_normal .a 255 to 588 16 to 349       334/349
(95 %)
6 diff
(98.3 %id)
BF197155 brain, glioblastoma (pooled) .a 259 to 753 1 to 495     Submitted on the opposite strand 495/495
(100 %)
8 diff
(98.4 %id)
BP269346 thyroid .a 266 to 843 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BP269977 thyroid .a 266 to 847 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ928228 epidermoid carcinoma, cell line, lung .a 313 to 1222 1 to 915       915/944
(96 %)
10 diff
(99.0 %id)
TI_57192067   .a 315 to 1013 17 to 718       702/718
(97 %)
10 diff
(98.7 %id)
CD617676   .a 334 to 1101 781 to 17       765/781
(97 %)
13 diff
(98.4 %id)
BI862703 breast, mammary adenocarcinoma, cell line .a 339 to 1013 12 to 687       676/687
(98 %)
10 diff
(98.6 %id)
BM917066 blood, natural killer cells, cell line .a 354 to 1435 1 to 1092       1092/1105
(98 %)
42 diff
(96.2 %id)
BM917827 blood, natural killer cells, cell line .a 354 to 985 1 to 635       635/935
(67 %)
8 diff
(99.2 %id)
BI117124 lung, small cell carcinoma .a 378 to 1206 1 to 831       831/905
(91 %)
12 diff
(98.7 %id)
CB116536 Liver .a 389 to 845 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
BE792127 lung, small cell carcinoma .a 398 to 1227 1 to 828       828/900
(92 %)
9 diff
(99.0 %id)
BU189482 melanotic melanoma, skin .a 402 to 1297 1 to 899       899/908
(99 %)
11 diff
(98.8 %id)
BQ073733 epidermoid carcinoma, cell line, lung .a 414 to 1036 1 to 626       626/1330
(47 %)
11 diff
(99.2 %id)
CN425523 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 442 to 1109 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
DA284084 corpus callosum .a 444 to 1023 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA727884   .a 446 to 1081 2 to 639   capped   638/638
(100 %)
3 diff
(99.6 %id)
CX787528 human embryonic stem cells .a 466 to 1270 1 to 805       805/805
(100 %)
0 diff
(100 %id)
CN425525 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 467 to 1046 1 to 578       576/578
(99 %)
6 diff
(99.0 %id)
BE732323 choriocarcinoma, placenta .a 490 to 1204 1 to 709       709/989
(71 %)
15 diff
(98.5 %id)
BF802129 colon_ins .a 501 to 772 272 to 3     Submitted on the opposite strand 270/272
(99 %)
13 diff
(95.3 %id)
BQ215779 embryonal carcinoma, cell line, testis .a 517 to 1226 177 to 894       718/802
(89 %)
17 diff
(97.9 %id)
CB148717 Liver .a 520 to 1109 1 to 590       590/590
(100 %)
0 diff
(100 %id)
TI_1948130672   .a 543 to 1427 1001 to 124       878/1161
(75 %)
16 diff
(98.7 %id)
BI006680 kidney_tumor .a 544 to 913 1 to 370       370/370
(100 %)
11 diff
(97.1 %id)
AA626734 lung, lung carcinoma .a 567 to 1047 1 to 481       481/481
(100 %)
5 diff
(99.0 %id)
BM755164 stomach .a 600 to 1006 1 to 406       406/406
(100 %)
2 diff
(99.6 %id)
TI_1948131330   .a 627 to 1427 927 to 126       802/1195
(67 %)
6 diff
(99.5 %id)
BG287069 bladder, transitional cell papilloma, cell line .a 629 to 1359 1 to 731       731/731
(100 %)
5 diff
(99.4 %id)
BI160215 epithelioid carcinoma cell line, Pancreas .a 638 to 1402 1 to 767       767/767
(100 %)
19 diff
(97.6 %id)
BG422221 Kidney, renal cell adenocarcinoma .a 655 to 1408 1 to 798       723/829
(87 %)
64 diff
(92.3 %id)
BG423800 Kidney, renal cell adenocarcinoma .a 656 to 1389 1 to 763       735/1013
(72 %)
59 diff
(94.2 %id)
CD580094 brain .a 656 to 1326 1 to 671       671/671
(100 %)
0 diff
(100 %id)
CD105868 brain, Pituitary .a 657 to 1504 1 to 847       847/847
(100 %)
7 diff
(99.2 %id)
BE746720 adenocarcinoma cell line, ovary .a 667 to 1467 1 to 806       806/960
(83 %)
14 diff
(98.6 %id)
CN425524 embryonic stem cells, DMSO-treated H9 cellline .a 669 to 1388 1 to 720       720/720
(100 %)
1 diff
(99.9 %id)
BG327003 Kidney, renal cell adenocarcinoma .a 704 to 1442 1 to 737       737/738
(99 %)
9 diff
(98.8 %id)
BQ278785 adenocarcinoma, cell line, breast .a 720 to 1606 1 to 898       898/1015
(88 %)
26 diff
(97.5 %id)
BU538022 adenocarcinoma, cell line, breast .a 720 to 1678 1 to 964       964/969
(99 %)
44 diff
(95.5 %id)
BU538076 adenocarcinoma, cell line, breast .a 720 to 1556 1 to 839       839/888
(94 %)
18 diff
(98.0 %id)
BU557893 adenocarcinoma, cell line, breast .a 720 to 1664 1 to 946       946/946
(100 %)
7 diff
(99.3 %id)
BU856787 adenocarcinoma, cell line, breast .a 720 to 1608 1 to 900       900/924
(97 %)
19 diff
(98.0 %id)
BU860307 adenocarcinoma, cell line, breast .a 720 to 1557 1 to 838       838/838
(100 %)
3 diff
(99.7 %id)
BU944105 adenocarcinoma, cell line, breast .a 720 to 1617 1 to 909       909/953
(95 %)
17 diff
(98.3 %id)
BU944691 adenocarcinoma, cell line, breast .a 720 to 1595 1 to 882       882/884
(99 %)
13 diff
(98.6 %id)
BU956291 adenocarcinoma, cell line, breast .a 720 to 1549 1 to 834       834/872
(95 %)
13 diff
(98.6 %id)
BF932922 nervous_tumor .a 723 to 922 207 to 8     Submitted on the opposite strand 200/210
(95 %)
1 diff
(99.6 %id)
BF207038 brain, neuroblastoma .a 730 to 1466 1 to 746       746/1063
(70 %)
14 diff
(98.7 %id)
BF315333 brain, neuroblastoma .a 730 to 1379 1 to 650       650/652
(99 %)
2 diff
(99.7 %id)
BM697744 eye, fetal eyes .a 736 to 1234 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BX402313 Placenta Cot 25-normalized .a 749 to 1763 1012 to 1       1014/1103
(91 %)
15 diff
(98.7 %id)
BG340892 B-cells, primary B-cells from tonsils (cell line) .a 782 to 1447 1 to 662       662/790
(83 %)
6 diff
(99.3 %id)
BG758508 B-cells, primary B-cells from tonsils (cell line) .a 782 to 1677 1 to 900       900/901
(99 %)
24 diff
(97.4 %id)
BM911199 astrocytoma grade IV, cell line, brain .a 799 to 1469 4 to 675       671/993
(67 %)
20 diff
(98.0 %id)
BI084555 epidermoid carcinoma, cell line, salivary gland .a 800 to 1720 924 to 4       921/976
(94 %)
27 diff
(97.3 %id)
AL547767 placenta, Placenta Cot 25-normalized .a 816 to 1747 935 to 13       923/941
(98 %)
8 diff
(99.2 %id)
AW958680   .a 818 to 1418 1 to 601       601/605
(99 %)
11 diff
(98.2 %id)
AL562095 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 821 to 1771 951 to 6   fully sequenced,   946/951
(99 %)
2 diff
(99.8 %id)
BQ324789 colon_ins .a 831 to 1208 9 to 386       378/386
(97 %)
7 diff
(98.2 %id)
BQ324798 colon_ins .a 831 to 1208 9 to 386       378/386
(97 %)
7 diff
(98.2 %id)
BF810363 colon_ins .a 834 to 1205 1 to 372       372/372
(100 %)
2 diff
(99.5 %id)
BF810471 colon_ins .a 834 to 1205 1 to 372       372/372
(100 %)
2 diff
(99.5 %id)
BQ324790 colon_ins .a 835 to 1208 28 to 401       374/401
(93 %)
10 diff
(97.6 %id)
BQ324799 colon_ins .a 835 to 1208 28 to 401       374/401
(93 %)
10 diff
(97.6 %id)
AL582585 B cells from Burkitt lymphoma .a 838 to 1760 924 to 1   fully sequenced,   924/924
(100 %)
5 diff
(99.5 %id)
BF852576 lung_normal .a 841 to 1385 1 to 548       548/552
(99 %)
11 diff
(98.1 %id)
AW797691 uterus .a 842 to 1276 450 to 15       436/451
(96 %)
1 diff
(99.8 %id)
AW797693 uterus .a 842 to 1274 442 to 12       431/443
(97 %)
1 diff
(99.8 %id)
AW797759 uterus .a 842 to 1267 452 to 29       424/453
(93 %)
1 diff
(99.8 %id)
AA312398   .a 849 to 1289 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
BQ670689 epidermoid carcinoma, cell line, salivary gland .a 857 to 1792 1 to 941   AAA   941/941
(100 %)
23 diff
(97.6 %id)
BE740525 adenocarcinoma cell line, ovary .a 861 to 1654 1 to 788       788/980
(80 %)
13 diff
(98.7 %id)
BQ329409 lung_normal .a 863 to 1381 41 to 566       529/592
(89 %)
14 diff
(97.7 %id)
AW797696 uterus .a 869 to 1271 28 to 429       401/434
(92 %)
9 diff
(98.0 %id)
TI_1948131329   .a 873 to 1427 720 to 159       562/1368
(41 %)
15 diff
(99.0 %id)
BE740769 adenocarcinoma cell line, ovary .a 895 to 1683 1 to 792       792/905
(87 %)
17 diff
(98.2 %id)
BE272349 adenocarcinoma cell line, ovary .a 933 to 1545 1 to 612       612/612
(100 %)
2 diff
(99.7 %id)
BI520597 brain, medulla .a 934 to 1727 832 to 18       815/882
(92 %)
20 diff
(97.8 %id)
TI_43963685   .a 934 to 1727 832 to 18       815/882
(92 %)
20 diff
(97.8 %id)
TI_159680013   .a 938 to 1792 979 to 130   AAA   850/967
(87 %)
23 diff
(97.7 %id)
TI_227714266   .a 951 to 1674 810 to 89   AAA   722/956
(75 %)
15 diff
(98.5 %id)
BM724560 eye, fetal eye .a 952 to 1276 1 to 325   fully sequenced,   325/325
(100 %)
0 diff
(100 %id)
AL578639 placenta .a 955 to 1764 803 to 1       803/803
(100 %)
13 diff
(98.4 %id)
BI160958 epithelioid carcinoma cell line, Pancreas .a 986 to 1793 1 to 820       820/837
(97 %)
26 diff
(96.9 %id)
BF083312 colon .a 994 to 1271 276 to 1       276/276
(100 %)
2 diff
(99.3 %id)
BF688935 eye, normal pigmented retinal epithelium .a 995 to 1771 783 to 10       774/783
(98 %)
5 diff
(99.4 %id)
AL528787 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 999 to 1779 779 to 1   fully sequenced,   779/779
(100 %)
24 diff
(97.0 %id)
BM040843 Kidney, Wilms' tumor, cell line .a 1003 to 1504 1 to 503   fully sequenced,   503/503
(100 %)
5 diff
(99.1 %id)
BM040995 Kidney, Wilms' tumor, cell line .a 1003 to 1258 1 to 256   fully sequenced,   256/256
(100 %)
1 diff
(99.7 %id)
TI_149287162   .a 1027 to 1792 872 to 106   AAA   767/1084
(70 %)
7 diff
(99.4 %id)
AL516137 brain, neuroblastoma, neuroblastoma cells .a 1028 to 1963 936 to 1       936/945
(99 %)
10 diff
(99.0 %id)
AA703988 bone marrow stroma .a 1028 to 1792 776 to 16   AAA   761/803
(94 %)
45 diff
(94.4 %id)
AI343293 colon, colon tumor, RER+ .a 1028 to 1791 762 to 1       762/769
(99 %)
2 diff
(99.8 %id)
TI_149292347   .a 1035 to 1792 836 to 77   AAA   760/911
(83 %)
8 diff
(99.2 %id)
TI_154037303   .a 1055 to 1792 815 to 93   AAA   723/799
(90 %)
26 diff
(96.8 %id)
BU502732 carcinoma, cell line, Prostate .a 1056 to 1792 1 to 738   AAA   738/738
(100 %)
2 diff
(99.8 %id)
AW394282 pnet .a 1057 to 1322 283 to 18       266/283
(93 %)
2 diff
(99.3 %id)
AW581489 pnet .a 1057 to 1287 241 to 5       237/241
(98 %)
2 diff
(99.2 %id)
AW581506 pnet .a 1057 to 1287 241 to 5       237/241
(98 %)
2 diff
(99.2 %id)
BQ931457 carcinoma, cell line, Prostate .a 1061 to 1666 1 to 613       613/1286
(47 %)
38 diff
(97.1 %id)
BF361282 pnet .a 1067 to 1291 1 to 228       228/228
(100 %)
8 diff
(96.5 %id)
BQ333366 pnet .a 1067 to 1291 1 to 228       228/228
(100 %)
8 diff
(96.5 %id)
CD364978 Alveolar Macrophage, lung .a 1073 to 1674 620 to 19   AAA   602/602
(100 %)
3 diff
(99.6 %id)
BX345739 Placenta Cot 25-normalized .a 1074 to 1743 677 to 1       677/744
(90 %)
5 diff
(99.4 %id)
AL575765 placenta, Placenta Cot 25-normalized .a 1074 to 2083 1006 to 1       1006/1006
(100 %)
9 diff
(99.2 %id)
TI_57186638   .a 1084 to 1795 55 to 765   AAA   711/1039
(68 %)
10 diff
(99.1 %id)
BI857004 breast, mammary adenocarcinoma, cell line .a 1085 to 1795 1 to 710       710/1050
(67 %)
10 diff
(99.1 %id)
BX357970.
matches multiple genes
Placenta Cot 25-normalized .a 1096 to 1741 668 to 21     also hits gene KLHL22andKRT18P5andSCARF2 648/760
(85 %)
21 diff
(97.3 %id)
BM974541 lung .a 1119 to 1792 695 to 19   AAA   677/677
(100 %)
3 diff
(99.6 %id)
BM972528 lung .a 1124 to 1792 688 to 19   AAA   670/670
(100 %)
1 diff
(99.9 %id)
CA307940 Alveolar Macrophage, lung .a 1135 to 1792 678 to 19   AAA   660/660
(100 %)
3 diff
(99.6 %id)
AI628467 Kidney .a 1140 to 1791 656 to 8       649/722
(89 %)
11 diff
(98.5 %id)
BU185660 ductal carcinoma, cell line, Pancreas .a 1140 to 1862 18 to 744       728/974
(74 %)
31 diff
(96.9 %id)
BQ646958 hepatocellular carcinoma, cell line, Liver .a 1141 to 1792 1 to 652   AAA   652/652
(100 %)
2 diff
(99.7 %id)
BQ645967 hepatocellular carcinoma, cell line, Liver .a 1141 to 1793 1 to 653       653/657
(99 %)
6 diff
(99.1 %id)
BQ649626 hepatocellular carcinoma, cell line, Liver .a 1141 to 1792 1 to 652   AAA   652/652
(100 %)
4 diff
(99.4 %id)
BU634293 cell lines, Chondrosarcoma .a 1141 to 1792 674 to 19   AAA   656/658
(99 %)
8 diff
(98.8 %id)
AI424378 Prostate .a 1145 to 1793 649 to 2       648/651
(99 %)
12 diff
(98.2 %id)
CA423606 cell lines, Chondrosarcoma .a 1154 to 1792 659 to 19   AAA   641/641
(100 %)
3 diff
(99.6 %id)
AI656382 pooled germ cell tumors .a 1189 to 1792 622 to 19   AAA   604/604
(100 %)
2 diff
(99.7 %id)
AI829173 adenocarcinoma, Pancreas .a 1189 to 1793 606 to 2       605/606
(99 %)
6 diff
(99.1 %id)
BG260045 bladder, transitional cell papilloma, cell line .a 1190 to 1990 9 to 809       801/872
(91 %)
27 diff
(97.0 %id)
BI850802 bladder, transitional cell papilloma, cell line .a 1196 to 1956 1 to 763       763/763
(100 %)
11 diff
(98.6 %id)
BM041663 Kidney, Wilms' tumor, cell line .a 1197 to 1716 519 to 1   fully sequenced,   519/519
(100 %)
1 diff
(99.9 %id)
W28213 eye, retina .a 1199 to 1670 1 to 474       474/511
(92 %)
15 diff
(97.1 %id)
BE739872 adenocarcinoma cell line, ovary .a 1221 to 1984 1 to 762       762/775
(98 %)
7 diff
(99.1 %id)
BU508190 leiomyosarcoma, uterus .a 1221 to 1792 1 to 572   AAA   572/572
(100 %)
2 diff
(99.7 %id)
BG575759 breast, mammary adenocarcinoma, cell line .a 1222 to 1792 1 to 571   AAA   571/571
(100 %)
0 diff
(100 %id)
AV760410 bone marrow .a 1223 to 1646 1 to 416       416/417
(99 %)
5 diff
(98.9 %id)
AI000662 breast .a 1238 to 1792 553 to 1       553/554
(99 %)
9 diff
(98.4 %id)
BU741727 eye, fetal eye .a 1246 to 1792 566 to 19   fully sequenced, AAA   548/548
(100 %)
1 diff
(99.9 %id)
AA633233 colon, colon tumor RER+ .a 1249 to 1792 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
BU736027 eye, fetal eyes .a 1256 to 1792 555 to 19   AAA   537/537
(100 %)
2 diff
(99.7 %id)
AW083234 colon, moderately differentiated adenocarcinoma .a 1270 to 1423 154 to 1       154/154
(100 %)
12 diff
(92.3 %id)
BF514945   .a 1281 to 1792 529 to 18   AAA   512/512
(100 %)
0 diff
(100 %id)
AI439234 lymph node, lymphoma, follicular mixed small and largecell .a 1287 to 1792 503 to 1       503/511
(98 %)
3 diff
(99.5 %id)
AI968883 pooled germ cell tumors .a 1288 to 1793 511 to 4       508/511
(99 %)
0 diff
(100 %id)
AI250830 lymph node, lymphoma, follicular mixed small and largecell .a 1289 to 1793 506 to 1       506/515
(98 %)
3 diff
(99.5 %id)
AI224464 lymph node, lymphoma, follicular mixed small and largecell .a 1294 to 1792 519 to 21   AAA   499/499
(100 %)
4 diff
(99.2 %id)
CB162737 Liver .a 1318 to 1954 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
CA444427 lung, Metastatic Chondrosarcoma .a 1319 to 1792 494 to 19   AAA   476/476
(100 %)
2 diff
(99.6 %id)
BF056026 pooled germ cell tumors .a 1321 to 1423 103 to 1       103/103
(100 %)
0 diff
(100 %id)
DB516368 testis .a 1328 to 1792 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
AI471610 Kidney .a 1333 to 1792 461 to 1       461/461
(100 %)
11 diff
(97.7 %id)
BE764114 nervous_tumor .a 1343 to 1653 317 to 7       311/317
(98 %)
0 diff
(100 %id)
BM691892 eye, human retina .a 1345 to 1790 4 to 449   fully sequenced,   446/449
(99 %)
6 diff
(98.7 %id)
AA668914 lung .a 1346 to 1793 449 to 4       446/449
(99 %)
0 diff
(100 %id)
BM695880 eye, human retina .a 1350 to 1582 1 to 233   fully sequenced,   233/233
(100 %)
0 diff
(100 %id)
BM703850 eye, human retina .a 1350 to 1744 1 to 395       395/395
(100 %)
0 diff
(100 %id)
BM715340 eye, human retina .a 1350 to 1792 1 to 443   AAA   443/443
(100 %)
0 diff
(100 %id)
TI_149297463   .a 1366 to 2140 823 to 55   AAA   769/952
(80 %)
12 diff
(98.8 %id)
BM982523 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1366 to 2140 785 to 17   AAA   769/776
(99 %)
12 diff
(98.5 %id)
AI745572 Prostate .a 1372 to 1793 424 to 3       422/424
(99 %)
0 diff
(100 %id)
AA705594   .a 1383 to 1793 405 to 1       405/405
(100 %)
5 diff
(98.8 %id)
AW779877 Kidney .a 1385 to 1794 416 to 7       410/416
(98 %)
0 diff
(100 %id)
BU728594 eye, human retina .a 1388 to 1792 423 to 19   fully sequenced, AAA   405/405
(100 %)
0 diff
(100 %id)
CD365951 Alveolar Macrophage, lung .a 1413 to 2163 767 to 19   tiling clone, AAA   749/749
(100 %)
5 diff
(99.4 %id)
CA427330 Cell Line, Chondrosarcoma .a 1415 to 2118 721 to 19   AAA   703/703
(100 %)
2 diff
(99.8 %id)
AA644096 lung, lung carcinoma .a 1418 to 1798 383 to 5       379/383
(98 %)
0 diff
(100 %id)
AI080698 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1423 to 1792 382 to 13   AAA   370/370
(100 %)
1 diff
(99.8 %id)
BU730589 eye, RPE and Choroid .a 1470 to 1792 344 to 19   AAA   326/328
(99 %)
12 diff
(96.4 %id)
BM041748 Kidney, Wilms' tumor, cell line .a 1474 to 1729 257 to 2   fully sequenced,   256/257
(99 %)
6 diff
(97.7 %id)
DB511862 testis .a 1476 to 1792 1 to 321     Submitted on the opposite strand 321/321
(100 %)
17 diff
(94.8 %id)
AW594693 pooled germ cell tumors .a 1477 to 1793 317 to 1       317/317
(100 %)
0 diff
(100 %id)
AI638510 pooled germ cell tumors .a 1478 to 1793 316 to 1       316/316
(100 %)
0 diff
(100 %id)
T23539   .a 1497 to 1793 299 to 3       297/299
(99 %)
0 diff
(100 %id)
AI436721 Kidney .a 1498 to 1793 297 to 2     Submitted on the opposite strand 296/305
(97 %)
0 diff
(100 %id)
AA330796 embryo .a 1500 to 1775 1 to 278       278/278
(100 %)
2 diff
(99.3 %id)
BE814751 breast_normal .a 1500 to 1792 24 to 316       293/337
(86 %)
5 diff
(98.6 %id)
EC530919 Prostate .a 1506 to 1585 1 to 78       78/88
(88 %)
2 diff
(97.8 %id)
AW393157 stomach .a 1514 to 1746 237 to 4       234/242
(96 %)
0 diff
(100 %id)
AI287794 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1526 to 1792 285 to 19   AAA   267/267
(100 %)
1 diff
(99.7 %id)
AI620156 Prostate .a 1526 to 1792 287 to 21   AAA   267/267
(100 %)
2 diff
(99.3 %id)
AW393139 stomach .a 1527 to 1767 38 to 279       242/287
(84 %)
14 diff
(95.2 %id)
AI417937 Prostate .a 1532 to 1792 279 to 19   AAA   261/261
(100 %)
0 diff
(100 %id)
BM666958 eye, human retina .a 1552 to 1792 260 to 19   fully sequenced, AAA   242/242
(100 %)
1 diff
(99.6 %id)
C20991   .a 1568 to 1792 1 to 226       226/226
(100 %)
2 diff
(99.2 %id)
AI424582 Prostate .a 1587 to 1792 206 to 1       206/207
(99 %)
0 diff
(100 %id)
BF062415 colon, colon tumor, RER+ .a 1588 to 1791 204 to 1       204/204
(100 %)
5 diff
(97.6 %id)
AI682102 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1599 to 1791 206 to 14       193/206
(93 %)
0 diff
(100 %id)
CR738952 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1633 to 1792 174 to 15   AAA   160/169
(94 %)
2 diff
(98.9 %id)
AW779363 Kidney .a 1725 to 2164 441 to 2       440/441
(99 %)
0 diff
(100 %id)
AI198352 anaplastic oligodendroglioma, brain .a 1766 to 2140 375 to 1       375/375
(100 %)
0 diff
(100 %id)
AW006230 anaplastic oligodendroglioma, brain .a 1774 to 2140 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AI198393 anaplastic oligodendroglioma, brain .a 1783 to 2140 358 to 1       358/358
(100 %)
0 diff
(100 %id)
BG531960 embryonal carcinoma, testis .a 1910 to 2515 72 to 674   tiling clone,   638/866
(73 %)
26 diff
(97.0 %id)
BX091836 Kidney .a 1929 to 2402 1 to 476       476/476
(100 %)
4 diff
(99.2 %id)
AA468045   .a 1955 to 2164 236 to 27       210/236
(88 %)
0 diff
(100 %id)
AI475000 anaplastic oligodendroglioma, brain .a 1993 to 2140 148 to 1       148/148
(100 %)
0 diff
(100 %id)
AI632019 Kidney .a 2043 to 2644 602 to 1       602/602
(100 %)
3 diff
(99.6 %id)
BU622861 cell lines, Enchondroma .a 2072 to 2631 578 to 19   AAA   560/560
(100 %)
1 diff
(99.9 %id)
AI650327 Kidney .a 2279 to 2631 353 to 1       353/353
(100 %)
0 diff
(100 %id)
BQ718326 sympathetic trunk .a 2296 to 2644 1 to 349   tiling clone, AAA   349/349
(100 %)
0 diff
(100 %id)
BG777763 adenocarcinoma, Prostate .a 2325 to 2634 1 to 310   AAA   310/310
(100 %)
1 diff
(99.7 %id)
CR622469 Neuroblastoma Cot 50-normalized .b 1 to 1640 4 to 1643 exact tiling clone,   1643/1643
(100 %)
0 diff
(100 %id)
DB263800 uterus .c 1 to 553 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DB351742 uterus .c 1402 to 1916 515 to 1   tiling clone,   515/515
(100 %)
0 diff
(100 %id)
AL534701 brain, fetal brain .d 1 to 652 1 to 651   tiling clone, fully sequenced,   651/651
(100 %)
17 diff
(97.4 %id)
BX400261   .d 1 to 915 1 to 914   tiling clone,   914/914
(100 %)
15 diff
(98.4 %id)
CR975994 T-Lymphocytes .d 110 to 552 1 to 443       443/480
(92 %)
0 diff
(100 %id)
AL565626 brain, fetal brain .d 617 to 1555 934 to 1   tiling clone, fully sequenced,   934/934
(100 %)
1 diff
(99.9 %id)
CR621542 fetal brain .e 1 to 1507 1 to 1507 exact tiling clone,   1507/1507
(100 %)
0 diff
(100 %id)
BQ928272 epidermoid carcinoma, cell line, lung .f 1 to 918 20 to 950 K184X K211X E235K P237Q A238Q ... tiling clone,   934/983
(95 %)
41 diff
(95.9 %id)
BF979453 testis .f 526 to 1138 1 to 612   tiling clone, fully sequenced,   612/612
(100 %)
8 diff
(98.7 %id)
AA383801 testis .f 637 to 930 1 to 294       294/294
(100 %)
1 diff
(99.7 %id)
BF980180 testis .f 1108 to 1714 611 to 4   tiling clone, fully sequenced,   608/611
(99 %)
5 diff
(99.2 %id)
BQ222206 epithelioid carcinoma, Pancreas .g 1 to 602 9 to 613 R107K K123Q L124T K125E E126R ... tiling clone, AAA   605/901
(67 %)
11 diff
(98.8 %id)
AA370390 Prostate .h 1 to 327 1 to 327 I36X T91X V106A S107N W108K tiling clone,   327/355
(92 %)
7 diff
(98.1 %id)
BF817970 colon_ins .i 1 to 431 452 to 24 I42T S43W G44P L45G E46A ... tiling clone, Submitted on the opposite strand 429/468
(91 %)
1 diff
(99.8 %id)
AW379339 head_neck .j-u 1 to 305 308 to 3 G14D tiling clone,   306/308
(99 %)
0 diff
(100 %id)
AW579724 head_neck .j-u 1 to 326 1 to 325 Q13R G14V V15L D17T T18L ... tiling clone,   325/329
(98 %)
6 diff
(98.2 %id)
AF019767   Gene ZNF259, variant not shown       AAA This clone was ignored    
BF755583 colon Gene ZNF259, variant not shown         Submitted on the opposite strand    
BQ292079 amnion_normal Gene ZNF259, variant not shown              
EH341945   Gene ZNF259, variant not shown              
DB450879 testis Gene ZNF259, variant not shown              
BE787116 large cell carcinoma, lung Gene ZNF259, variant not shown              
BE795283 lung, small cell carcinoma Gene ZNF259, variant not shown         Suspected internal deletion, this clone was ignored    
BF664001 B-cells, primary B-cells from tonsils (cell line) Gene ZNF259, variant not shown              
BG032714 breast, mammary adenocarcinoma, cell line Gene ZNF259, variant not shown              
BG338438 leiomyosarcoma cell line, uterus Gene ZNF259, variant not shown              
BG338781 leiomyosarcoma cell line, uterus Gene ZNF259, variant not shown              
BI827240 brain, medulla Gene ZNF259, variant not shown              
BQ431809 melanotic melanoma, skin Gene ZNF259, variant not shown              
BU521186 leiomyosarcoma, uterus Gene ZNF259, variant not shown              
BU543418 carcinoma, cell line, Prostate Gene ZNF259, variant not shown              
TI_227715651   Gene ZNF259, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BU623976 cell lines, Enchondroma Gene ZNF259, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CD366771 Alveolar Macrophage, lung Gene ZNF259, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI